TNFRSF17 and Miyoshi myopathy: Actually, studies performed in vitro on BCMA+ cell lines and in vivo on murine models and ex vivo assays on bone marrow samples from MM patients showed that this drug selectively mediates apoptosis of BCMA+ cells by recruiting T-cells [73].